Podium to Practice: EHA 2026 – Leukemia: Bridging Strategies to Allo-SCT in B-ALL
OR
Studies / Trials Discussed
S111 – ANTIBODY-BASED IMMUNOTHERAPY VERSUS CELLULAR THERAPY AS BRIDGING TO ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY OR MRD-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Chair
Explore more from your favourite experts – click their name to access their entire library of content.
Studies/trials discussed:
S111 – ANTIBODY-BASED IMMUNOTHERAPY VERSUS CELLULAR THERAPY AS BRIDGING TO ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY OR MRD-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Login to view content
PLease Enter Your Email to view Content
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.